Picture of Ascentage Pharma International logo

6855 Ascentage Pharma International Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Annual cashflow statement for Ascentage Pharma International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-347-1,482-675-832-887
Depreciation
Amortisation
Non-Cash Items63.798485.813.467.4
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital27.111.1-47.7186104
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-238-460-610-605-654
Capital Expenditures-49.5-81.4-251-457-257
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items342-120144-9.89-128
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities293-201-107-467-385
Financing Cash Flow Items-6.52-32.3-19.3-32.9-49.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities8604421,0401,781619
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash942-218281687-361